Novel nucleic acids, polypeptides, methods of making, and uses thereof
CA 2451058 A1 · Owner: Murphy, Andrew J. · Inventors: Glass, David J.; Murphy, Andrew J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
HUMAN LGR9 GPCR polypeptides and related nucleic acids are provided. Included are natural HUMAN LGR9 GPCR homologs from several species and polypeptides comprising a HUMAN LGR9 GPCR domain having specific activity. The polypeptides may be produced recombinantly from transformed host cells with the subject nucleic acids. Also provided are 10 isolated hybridization probes and oligonucleotide primers capable of specifically hybridizing with the disclosed genes, specific binding agents and methods of making and using the subject compositions, including high throughput screens.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 19, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 19, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.